Aβ targeted |
Increase |
Aβ42, APP, sAPPβ, BACE-1 |
|
Decrease |
Aβ42, APP |
|
No change |
Aβ42, APP, sAPPα, sAPPβ, BACE-1, Aβ42/p-T181-tau, γ-secretase |
Tau targeted |
Increase |
t-tau, p-T181-tau, p-T231-tau, p-S202-tau, p-S396-tau, p-tau/t-tau, p-T181-tau/t-tau,-tau/Aβ42 |
|
Decrease |
t-tau |
|
No change |
t-tau, p-T181-tau, p-S396-tau, p-T181-tau/t-tau, t-tau/Aβ42, N-224 tau, N-123 tau, MR tau, FL tau |
Synaptic protein |
Decrease |
NRGN, synaptophysin, synaptotagmin, synaptopodin, SNAP-25, AMPA4 receptor, NPTX2, NLGN1, NRXN2, p-S9-synapsin 1, synapsin 1, MOG |
Autolysosomal |
Increase |
cathepsin D, LAMP-1 |
|
No change |
cathepsin D, LAMP-1 |
Growth/trophic |
Increase |
GDNF |
|
Decrease |
GDNF, FGF-2, FGF-13, HGF, IGF-1 |
Brain insulin resistance |
Increase |
p-Y-IRS-1, p-S312-IRS-1, p-S312-IRS-1/p-Y-IRS-1 |
|
Decrease |
p-Y-IRS-1 |
|
No change |
t-IRS-1, p-Y-IRS-1, p-S312-IRS-1, p-S312-IRS-1/p-Y-IRS-1 |
Inflammatory related |
Increase |
MMP-9, TSPO |
|
No change |
IL-6 |
Molecular chaperone |
Increase |
ubiquitinylated protein |
|
Decrease |
HSP70 |
|
No change |
HSP70, ubiquitinylated protein |
Transcriptional repressor |
Decrease |
REST |
Cell type marker |
Increase |
GFAP, NF-Lch, NS-enolase |
|
Decrease |
GFAP, GluSyn |
|
No change |
GluSyn, NF-Lch, NS-enolase |
Exosome marker |
Decrease |
CD81 |
|
No change |
CD81, TSG101 |
Other |
Increase |
GM1 |
|
Decrease |
GAP43, Septin-8 |
|
No change |
Septin-8 |